feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Universal flu vaccine challenge

trending

Man City vs Brentford LIVE

trending

Mammoth vs. Red Wings game

trending

Micron stock soars on AI

trending

Phillies land Brad Keller

trending

Atletico Baleares vs Atletico Madrid

trending

Cavaliers vs. Bulls watch

trending

Dolphins to release Matthew Judon

trending

Celtic faces Dundee United

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Alzheimer's Blood Test: Early Detection Breakthrough

New Alzheimer's Blood Test: Early Detection Breakthrough

17 Dec

•

Summary

  • Alzheimer's more prevalent in over-85s than previously thought.
  • Blood test identifies Alzheimer's biomarkers, aiding early detection.
  • 11% of over-70s eligible for drugs slowing early disease stages.
New Alzheimer's Blood Test: Early Detection Breakthrough

New research indicates a higher prevalence of Alzheimer's disease among individuals over 85, surpassing previous estimates. The study utilized a straightforward blood test to identify specific protein biomarkers associated with cognitive decline, underscoring the significance of early detection.

Analysis of over 11,000 blood samples revealed that Alzheimer's disease neuropathological changes (ADNC) increased with age. Notably, approximately 11% of participants over 70 met the criteria for antibody treatments that can potentially slow the disease's progression, suggesting a substantial number could benefit from early intervention.

Experts emphasize that detecting dementia signs early is vital for addressing this global challenge. While these blood tests show promise for widespread use, further evidence is needed for NHS integration, as current diagnostic methods include lumbar punctures and PET scans.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The study found Alzheimer's disease is more common in people over 85 and that a simple blood test can detect early signs, making 11% of over-70s eligible for treatments.
Currently, blood tests for Alzheimer's are not widely available on the NHS, but trials are underway to assess their effectiveness for health service use.
Approximately 11% of individuals aged 70 and above could be eligible for antibody treatments that slow the early stages of Alzheimer's disease.

Read more news on

Healthside-arrow

You may also like

Ageing or Dementia: Spotting the Signs

13 Dec • 36 reads

article image

Neighbors Vanish: UK Faces Loneliness Crisis

12 Dec • 44 reads

article image

Parkinson's Risk: 5 Steps to Protect Your Brain

10 Dec • 59 reads

article image

Smell Loss: A Hidden Brain Warning?

7 Dec • 62 reads

article image

Driving Habits Hint at Alzheimer's Risk

3 Dec • 94 reads

article image